FIELD: medicine.
SUBSTANCE: invention refers to method for prevention of mirtazapin sublimation from a pharmaceutical preparative form containing solid enantiomer pure form of mirtazapin, by making the preparative forms by addition of at least one pharmaceutically acceptable adjuvant to the solid form of mirtazapin enantiomer. The enantiomer pure form is pharmaceutically acceptable, nonsublumating and solid salt of S- or R-mirtazapin. There are also described nonsublumating salts of S-mirtazapin and the pharmaceutical preparative form of the latter.
EFFECT: higher efficiency of the composition.
4 cl, 4 tbl, 8 ex
| Title |
Year |
Author |
Number |
| METHOD OF OBTAINING ENANTIOMERICALLY PURE MIRTAZAPINE |
2004 |
- Viringa Jokhannes Khjubertus
- Van De Ven Adrianus Antonius Martinus
- Kemperman Gerardus Jokhannes
|
RU2352566C2 |
| METHOD FOR SEPARATION OF BACLOFEN SALTS |
2017 |
- Kokrel, Zherar
- Majo, Zhulen
- Zhendron, Fransua-Ksave
|
RU2743999C2 |
| ENANTIOSELECTIVE SYNTHESIS OF 6-AMINO-7-HYDROXY-4,5,6,7-TETRAHYDROIMIDAZO[4,5,1-jk][1]BENZAZEPIN-2[1H]-ONE AND ZILPATEROL |
2008 |
- Al'Mena-Pereha Khuan Khose
- Brink Monika
- Gajss Gerkhard
- Kadyrov Renat
- Mejer Torsten
|
RU2433131C2 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRILINDOLE ENANTIOMERS FOR USE IN MEDICINE |
2014 |
- Pardal Filipe, Augusto Eugenio
- Eufrasio Pedroso, Pedro Filipe
- Almeida Pecorelli, Susana Marques
- Casimiro Caixado, Carlos Alberto Eufrasio
- Lopes, Ana Sofia Da Conceicao
- Damil, Joao Carlos Ramos
- E Oliveira Santos, Pedro Paulo De Lacerda
|
RU2706688C2 |
| COMBINATION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS SUFFERING WITH DEPRESSION |
1997 |
- Nikkol'Son Viktor Jokhannes
|
RU2181287C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING (S)-(-)-2-(4-ISOBUTYL- -PHENYL)-PROPIONATE SODIUM, METHOD OF SYNTHESIS OF 2-(4- -ISOBUTYLPHENYL)-PROPIONIC ACID SODIUM SALT ENANTIOMER, (S)-(-)-2-(4-ISOBUTYLPHENYL)-PROPIONATE SODIUM DIHYDRATE |
1992 |
- Bernard Dzhon Armitedzh
- Pol Frederik Ko
- Dzhon Frensis Lampard
- Alan Smit
|
RU2145219C1 |
| OPTICALLY PURE Na, Mg, Li, K OR Ca SALTS OF (-)-5-METHOXY-2-[[(4- -METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZ-IMIDAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND INTERMEDIATE COMPOUND |
1994 |
- Per Lennart Lindberg
- Sverker Von Unge
|
RU2137766C1 |
| MIRTAZAPINE-CONTAINING ORALLY DECOMPOSING COMPOSITION |
2000 |
|
RU2261098C2 |
| ACTIVE ENANTIOMER OF DODECYL 2-(N,N-DIMETHYLAMINO)-PROPIONATE |
2011 |
- Damazh Bassam B.
- Martin Richard
|
RU2679308C2 |
| METHOD OF TREATMENT OF ENURESIS USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBYTININ |
1997 |
- Aberg Gunnar
- Mak Kallou Dzhon R.
|
RU2195276C2 |
